Results 131 to 140 of about 28,213 (299)

Paraneoplastic sclerodermiform syndrome--case report. [PDF]

open access: yes, 2014
Occasionally, auto-immune diseases may emerge as paraneoplastic syndromes. This is especially recognized in the case of polymyositis/dermatomyostis, but it is an extremely rare event in systemic sclerosis (SSc).
Abreu, P   +6 more
core  

A Case of Paraneoplastic Stiff-person Syndrome with Advanced Breast Cancer

open access: diamond, 2020
Daisuke Naito   +5 more
openalex   +2 more sources

Pharmacovigilance Insights Into Immune Checkpoint Inhibitor‐Induced Risk of Paraneoplastic Syndrome: A Large‐Scale Real World Study

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Immune checkpoint inhibitors are associated with rare but severe paraneoplastic syndromes, particularly in lung cancer patients. PS onset shows a bimodal pattern, with increased severity seen in combination therapies like durvalumab plus tremelimumab.
Bufu Tang   +12 more
wiley   +1 more source

Mimics and Diagnostic Pitfalls of Anti‐Adenylate Kinase 5 Limbic Encephalitis

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Mimics of anti‐AK5 encephalitis are common and that misdiagnosis is often driven by non‐specific symptoms and clinically irrelevant antibody results. The absence of cognitive impairment as a major symptom, prominence of psychiatric and behavioral symptoms, isolated from serum positivity or low CSF antibody titers (< 1:100), and objective clinical ...
Jierui Wang   +5 more
wiley   +1 more source

Paraneoplastic Syndromes

open access: yesBrain Pathology, 1999
Giometto B, Scaravilli F
openaire   +4 more sources

Peripheral Signatures of Multidimensional Pathology in Symptomatic and Asymptomatic Creutzfeldt–Jakob Disease

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
Plasma biomarkers in CJD reveal multisystem involvement, with neuronal injury markers showing strong discriminative performance and vascular proteins indicating blood–brain barrier dysfunction. In asymptomatic PRNP mutation carriers, biomarker changes are minimal and emerge mainly near disease onset ABSTRACT Background Plasma markers of neuronal injury
Zhong‐Yun Chen   +11 more
wiley   +1 more source

Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration

open access: yesAnnals of Clinical and Translational Neurology
Objective Patients with ovarian cancer (OC) may develop anti‐Yo‐associated paraneoplastic cerebellar degeneration (PCD)—a cerebellar ataxia associated with tumor‐induced autoimmunity against CDR2 and CDR2L proteins.
Eirik Tveit Solheim   +7 more
doaj   +1 more source

Hodgkin Lymphoma With Liver Involvement (Diagnostic, Therapeutic Difficulties, and Literature Review): A Retrospective Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims In classical Hodgkin lymphoma liver involvement occurs in 5%–8%, ranging from mild dysfunction to acute liver failure. Recognition and treatment of advanced cases are challenging due to rapid progression and limited use of therapies. Methods We analyzed the data of 250 Hodgkin lymphoma patients; 9 had liver involvement, one
Fanni Borics   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy